Drug Discovery Services Market Size, Trends & Growth Opportunity By Process (Target Selection, Validation, and Lead Optimization), By Type (DMPK, and Medicinal Chemistry), By Drug Type (Biologics, and Small Molecules), By Therapeutics (Oncology, and Neurology), By Region and Forecast till 2027
Report ID : QR10024 | Industries : Healthcare | Published On :September 2021 | Page Count : 256Global Drug Discovery Services Market
Global Drug Discovery Services Market was valued at 10.2 billion in 2019 which is expected to reach USD 23.4 billion by 2027 at a CAGR 14.2%.
Qualiket Research’s latest report on ‘’Global Drug Discovery Services Market’’ contains qualitative and quantitative estimation of market elements that interests the clients. The increase in research and development investment and funding in pharmaceutical and biopharmaceutical industry thus raise demand for outsourcing analytical testing and clinical trial services.
Drug discovery is the process where new drugs are designed random screening, drug metabolites, molecular designing, drug metabolites, molecular designing, and serendipity. Drug discovery services mainly designed to reduce cost and timelines of drug discovery process. Drug discovery processes are used to development of new drugs.
Know more about this report: request for sample pages
Global Drug Discovery Services Market Drivers
Increase in prevalence of chronic diseases like cancer is expected to boost the growth of global drug discovery service market. For instance, according to WHO (World Health Association) around 8.8 million people are dead due to cancer in 2015 worldwide. Furthermore, rise in demand for medicine for treatment of various diseases is expected to propel the global drug discovery services market growth. In addition to that, rise in technological advancements, new drug discovery techniques, as well as increase in demand for generic medicine expected to fuel the global drug discovery market growth.
Global Drug Discovery Services Market Restraints
Huge capital investments, and low profit margins are the major restraining factors which is expected to hamper the global drug discovery services market growth. Also, strict Food and Drug Administration (FDA) regulations and poor healthcare system will affect the growth of global drug discovery services market.
Global Drug Discovery Services Market Segmentation
On the basis of process, the global drug discovery services market is segmented into Target Selection, Validation, and Lead Optimization, on the basis of type market is segmented into DMPK, and Medicinal Chemistry.
Based on drug type market is segmented into biologics, and small molecules. In 2019, small molecule drugs projected to largest market share as these drugs are well-defined, small, simple, and easy to characterize. Due these unique features they can easily enter into cells, affect molecules, and kill cancer cells. Also, based on therapeutics market is segmented into oncology, and neurology.
Regional Analysis
On the basis of region global drug discovery services market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America projected for the largest market share of the drug discovery services market. The large market share of this drug discovery services market can be attributed majorly to the availability of well-established CROs, and increase in expenditure research and development expenditure by biopharmaceutical and pharmaceutical companies, and the availability of advanced techniques facilities for drug discovery research.
Impact of COVID 19
The COVID 19 pandemic is public health challenge and which is expected to have significant impact on ISH market for research and diagnostics applications. In order to expedite R & D process, leading pharma and biotech industries entering into partnership and collaboration with drug discovery organizations to develop vaccines and therapeutics to control COVID 19.
Key Features of Study
- The Global Drug Discovery Services Report provides detailed quantitative analysis of current market trends in drug discovery services, and market estimates from 2020 to 2027which showcase the drug discovery services market opportunities during this forecast timeline.
- In-depth analysis of this report covers analysis of various regions is anticipated to offer a detailed understanding of the latest market trends to enable stakeholders formulate region-specific plans.
- The Global Drug Discovery Services Market study contains qualitative and quantitative estimation of market elements which interests the clients.
Global Drug Discovery Services Market Key Competitors
Various key competitors are discussed in this report such as Albany Molecular Research Inc., Charles River Laboratories, International Domainex, Thermo Fischer Scientific, Covance, GenScript, Selcia Limited, SRI International, WuXI App Tec, Viva Biotech, Evotec, and Pharmaceutical Product Developmemt LLC.
Global Drug Discovery Services Market Taxonomy
By Process
- Target Selection
- Validation
- Lead Optimization
By Type
- DMPK
- Medicinal Chemistry
By Drug Type
- Biologics
- Small Molecules
By Therapeutics
- Oncology
- Neurology
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Drug Discovery Services Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
Global Drug Discovery Services Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Drug Discovery Services Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Drug Discovery Services Market, By Process
5.1 Y-o-Y Growth Comparison, By Process
5.2 Global Drug Discovery Services Market Share Analysis, By Process
5.3 Global Drug Discovery Services Market Size and Forecast, By Process
5.3.1 Target Selection
5.3.2 Validation
5.3.3 Lead Optimization
6 Global Drug Discovery Services Market, By Type
6.1 Y-o-Y Growth Comparison, By Type
6.2 Global Drug Discovery Services Market Share Analysis, By Type
6.3 Global Drug Discovery Services Market Size and Forecast, By Type
6.3.1 DMPK
6.3.2 Medicinal Chemistry
7 Global Drug Discovery Services Market, By Drug Type
7.1 Y-o-Y Growth Comparison, By Drug Type
7.2 Global Drug Discovery Services Market Share Analysis, By Drug Type
7.3 Global Drug Discovery Services Market Size and Forecast, By Drug Type
7.3.1Biologics
7.3.2 Small Molecules
8 Global Drug Discovery Services Market, By Therapeutics
8.1 Y-o-Y Growth Comparison, By Therapeutics
8.2 Global Drug Discovery Services Market Share Analysis, By Therapeutics
8.3 Global Drug Discovery Services Market Size and Forecast, By Therapeutics
8.3.1 Oncology
8.3.2 Neurology
9Global Drug Discovery Services Market, By Region
9.1 Global Drug Discovery Services Market Share Analysis, By Region
9.2 Global Drug Discovery Services Market Share Analysis, By Region
9.3 Global Drug Discovery Services Market Size and Forecast, By Region
10 North America Drug Discovery Services Analysis and Forecast (2020 – 2027)
10.1 Introduction
10.2 North America Drug Discovery Services Product Market Share Analysis, By Process
10.3 North America Drug Discovery Services Product Market Size and Forecast, By Type
10.4 North America Drug Discovery Services Product Market Size and Forecast, By Drug Type
10.5 North America Drug Discovery Services Product Market Size and Forecast, By Therapeutics
10.6 North America Drug Discovery Services Product Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11Europe Drug Discovery Services Market Analysis and Forecast (2020 – 2027)
11.1 Introduction
11.2 Europe Drug Discovery Services Product Market Share Analysis, By Process
11.3 Europe Drug Discovery Services Product Market Size and Forecast, By Type
11.4 Europe Drug Discovery Services Product Market Size and Forecast, By Drug Type
11.5 Europe Drug Discovery Services Product Market Size and Forecast, By Therapeutics
11.6 Europe Drug Discovery Services Product Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.64. Rest of Europe
12Asia Pacific Drug Discovery Services Market Analysis and Forecast (2020 – 2027)
12.1 Introduction
12.2 Asia Pacific Drug Discovery Services Product Market Share Analysis, By Process
12.3 Asia Pacific Drug Discovery Services Product Market Size and Forecast, By Type
12.4 Asia Pacific Drug Discovery Services Product Market Size and Forecast, By Drug Type
12.5 Asia Pacific Drug Discovery Services Product Market Size and Forecast, By Therapeutics
12.6 Asia Pacific Drug Discovery Services Product Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13Latin America Drug Discovery Services Market Analysis and Forecast (2020 – 2027)
13.1 Introduction
13.2 Latin America Drug Discovery Services Product Market Share Analysis, By Process
13.3 Latin America Drug Discovery Services Product Market Size and Forecast, By Type
13.4 Latin America Drug Discovery Services Product Market Size and Forecast, By Drug Type
13.5 Latin America Drug Discovery Services Product Market Size and Forecast, By Therapeutics
13.6 Latin America Drug Discovery Services Product Market Size and Forecast, By Country
14Middle East Drug Discovery Services Market Analysis and Forecast (2020 – 2027)
14.1 Introduction
14.2 Middle East Drug Discovery Services Product Market Share Analysis, By Process
14.3 Middle East Drug Discovery Services Product Market Size and Forecast, By Type
14.4 Middle East Drug Discovery Services Product Market Size and Forecast, By Drug Type
14.5 Middle East Drug Discovery Services Product Market Size and Forecast, By Therapeutics
14.6 Middle East Drug Discovery Services Product Market Size and Forecast, By Country
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16Company Profiles
16.1 Albany Molecular Research Inc
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Charles River Laboratories
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 International Domainex
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Thermo Fischer Scientific
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Covance
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 GenScript
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Selcia Limited
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 SRI International,
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 WuXI App Tec
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Viva Biotech
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
16.11 Evotec
16.11.1 Overview
16.11.2 Offerings
16.11.3 Key Financials
16.11.4 Business Segment & Geographic Overview
16.11.5 Key Market Developments
16.11.6 Key Strategies
16.12 Pharmaceutical Product Developmemt LLC
16.12.1 Overview
16.12.2 Offerings
16.12.3 Key Financials
16.12.4 Business Segment & Geographic Overview
16.12.5 Key Market Developments
16.12.6 Key Strategies